Prospection | Healthcare Data Analytics

Real world evidence finding the right patient for the right treatment

Support clinical decisions with actionable real world evidence

Using real world evidence to power precision medicine

We are Prospection

A Leading Provider of Actionable Real World Evidence

We aim to improve health outcomes by enabling evidence-based decisions. We use real world data to generate actionable patient-centric insights, to find misdiagnosed or undertreated patients, to publish evidence in collaboration with therapeutic experts and to support business and clinical decision making.

The Prospection Advantage

Real World Insights

We take untethered patient and pharma data to map treatment and patient journeys, translating it into actionable insights. Target treatments like never before and pinpoint opportunities for treatment intervention.

Commercial Effectiveness

Prospection is dedicated to improving treatment outcomes. We are partnered with global pharmaceutical companies with successful large-scale projects and have extensive reach throughout the Asia Pacific, UK and USA.

Advanced Analytics

The ability for machine learning to analyse patterns in data far exceeds our own. Prospection-developed algorithms consider geospatial and patient data alongside each other to identify target patient cohorts, treatment barriers, opportunities for better health outcomes and more.

Secure Environment

Data is our greatest asset, so we protect it with the highest levels of security. We only work with trusted data vendors for secure, uncorrupted information.

Harnessing real world data to improve patient outcomes

A secure, powerful, evidentiary solution; everything that Prospection does is for the betterment of patients.

Prospection is helping you make evidence-based decisions with our proprietary health data analytics solutions. We have developed a powerful set of tools that offers unprecedented speed to therapeutic evidence, understanding patient cohorts to show where and when treatment outcomes can be improved in the real world setting.

We gather and present longitudinal patient data in easily searchable dashboards, presented in pharma-minded formats to give you quick access to business critical information. From specialised treatment journeys to mapping patient trends, our analytic offerings are scalable to your market.

For further detail, have a look at what our services can provide.

Data
Analytics

Longitudinal
Patient Data

Pharma
Intelligence

Data
Mapping

Geo Spatial
Mapping

Big Data
Science

How we make an impact

Patient Insights

Our AI algorithms are able to gather historical data for millions of patients to give us comprehensive insights into healthcare journeys. Leveraging this information, we are unlocking new understandings to develop the most effective treatments, right down to the individual patient.

Tactics and Patient Finding

Analytics is a quality in, quality out process. We have developed algorithms using clean datasets for 90+ disease areas, allowing proactive early identification of untreated/under-treated patients. Our applied medical data tactics are finding both barriers to and opportunities for treatment, grouping similar patient cohorts and reducing diagnostic and treatment delays.

Real World Evidence

Incorporating more data, across larger demographics, delivered to decision makers faster than ever before. Our Real World Evidence complements clinical trial data to show treatment adoption and effectiveness in the wider population. Statistical methodology powered by Prospection software is upheld to the rigorous standards of medical research.

Decisions Support

Enabled by real world evidence, we deliver decision support directly to clinicians when they need it most. Providing therapeutic information, recommendations and support directly through clinician software with the help of our software partners.

What Our Clients Say

“The comorbidity data has added a lot of depth and insight. The patient model has also been extremely useful. I have very much appreciated your extra assistance when it has been needed, and look forward to continuing to work with you.”

“The team at Prospection have significantly changed the way we look at our market. It’s not just the data – one of a kind – but the partnership that makes this information come alive.”

“Massive thanks for this Oncology work. My marketing, medical and market access colleagues were very impressed with the unique insights all of these deliveries provided, in a market where real world robust data is difficult to obtain.”

“You sparked some great collaboration opportunities within the group which was fantastic to see and some real curiosity around how we can leverage this type of data. Your excitement about the data and the possibilities was infectious and your passion for improving patient outcomes really resonated with the team. We value the relationship with Prospection and the external perspective that you are able to offer.”

“Working with Prospection we were able to produce evidence in five weeks that may have taken five years in a clinical trial.”

The Prospection team are experts in data mining and RWE evidence generation. I have been working with them on a range of projects. For each of them they started by trying to understand the Key Business Questions to find the best approach to answer them. The team has a standard project set-up but it is completely tailored around client needs. Communication is seamless and they are happy and willing to go the extra mile.” Global pharma senior executive in rare disease.

September 5, 2022
1:04 pm

Japan healthcare data access agreement

Prospection announces a unique data access agreement with leading Japanese medical data company Medical Data Vision Co., Ltd. (MDV).

August 31, 2022
3:18 pm

The Democratisation of Real-World Evidence

Real-world evidence is playing an increasingly important role in healthcare delivery.

July 8, 2022
12:22 pm

Real world use of antipsychotic medication

A recent publication using Prospection’s real-world data analytics shows, 1 in 5 Australian patients with schizophrenia [1] is medicated with older typical long acting injectable (LAI) antipsychotics. Schizophrenia is one of the to...